[Federal Register Volume 76, Number 73 (Friday, April 15, 2011)]
[Notices]
[Pages 21416-21418]
[FR Doc No: 2011-9121]

-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

[Release No. 34-64292; File No. SR-ISE-2011-22]

Self-Regulatory Organizations; International Securities Exchange,
LLC; Notice of Filing and Immediate Effectiveness of Proposed Rule
Change Relating to Network Fees

April 11, 2011.
    Pursuant to Section 19(b)(1) of the Securities Exchange Act of 1934
(the ``Act''),\1\ and Rule 19b-4 thereunder,\2\ notice is hereby given
that on April 7, 2011, the International Securities Exchange, LLC (the
``Exchange'' or the ``ISE'') filed with the Securities and Exchange
Commission the proposed rule change, as described in Items I, II, and
III below, which items have been prepared by the self-regulatory
organization. The Commission is publishing this notice to solicit
comments on the proposed rule change from interested persons.
---------------------------------------------------------------------------

    \1\ 15 U.S.C. 78s(b)(1).
    \2\ 17 CFR 240.19b-4.
---------------------------------------------------------------------------

I. Self-Regulatory Organization's Statement of the Terms of Substance
of the Proposed Rule Change

    The ISE is proposing to adopt fees for a 10 Gigabit network
connection. The text of the proposed rule change is available on the
Exchange's Web site (http://www.ise.com), at the principal office of
the Exchange, and at the Commission's Public Reference Room.

II. Self-Regulatory Organization's Statement of the Purpose of, and
Statutory Basis for, the Proposed Rule Change

    In its filing with the Commission, the self-regulatory organization
included statements concerning the purpose of, and basis for, the
proposed rule change and discussed any comments it received on the
proposed rule change. The text of these statements may be examined at
the places specified in Item IV below. The self-regulatory organization
has prepared summaries, set forth in sections A, B and C below, of the
most significant aspects of such statements.

A. Self-Regulatory Organization's Statement of the Purpose of, and
Statutory Basis for, the Proposed Rule Change

1. Purpose
    The purpose of this proposed rule change is to amend the Exchange's
Schedule of Fees to adopt fees for a 10 Gigabit (GB) network
connection. The Exchange currently has a tiered

structure for the Ethernet/Managed Service Provider fee charged to
Members. The Ethernet/Managed Service Provider fee is a fee charged to
ISE Members to access the ISE's trading system via an Ethernet
connection or via a third-party managed service provider. The Ethernet/
Managed Service Provider connection carries the same information (such
as quotation and trade information) as other forms of connection (such
as T-1 and T-3 point-to-point connections).
    An Ethernet/Managed Service Provider connection enables users to
acquire bandwidth in megabit increments. The Exchange currently charges
Members $100 per month for a member's purchase of up to 10 Megabits
(MBs) of connection speed, $250 per month for the purchase of 11-100
MBs of connection speed and $500 per month for the purchase of 101
MBs-- 1 GB of connection speed. These fees are charged on a per
connection basis.
    The Exchange is scheduled to launch an enhanced trading platform
called Optimise on April 11, 2011. Upon transitioning to the Optimise
trading platform, ISE will offer a new network connectivity option for
Members. One of the many perceived advantages that the Optimise trading
platform will offer is greatly improved capacity and throughput. To
allow Members to maximize Optimise's low latency, ISE will offer a
connectivity option of 10 GBs. ISE proposes to charge Members a fee of
$4,000 per month for this 10 GB connection. ISE will retain the current
Ethernet connectivity options that are available to Members today.
    Once Optimise is rolled out, and until the Exchange has fully
transitioned from the current trading platform to the Optimise trading
platform, market makers will be required to maintain connections to
both trading systems. Therefore, ISE proposes to waive the new 10 GB
fee for all members until the migration is entirely completed. The
Exchange notes that the fees proposed herein are intended to cover and
are reasonably related to ISE's costs of rolling out and supporting the
new service.
    The Exchange has designated this proposal to be operative on April
11, 2011.
2. Statutory Basis
    The Exchange believes that the proposed rule change is consistent
with the provisions of Section 6 of the Act,\3\ in general, and with
Section 6(b)(4) of the Act,\4\ in particular, in that it provides for
the equitable allocation of reasonable dues, fees and other charges
among Exchange members and other persons using its facilities. In
particular, the proposed rule change will provide greater transparency
into the connectivity options available to market participants. The
proposed rule change treats similarly situated Members in the same
manner by assessing the same fees to all Members based on their
connectivity needs. The Exchange notes that the 10 GB connectivity
option proposed herein is similar to that currently in place at other
exchanges. For example, NASDAQ OMX PHLX, Inc. (``PHLX''), NASDAQ OMX
BX, Inc. (``BX'') and the NASDAQ Stock Market LLC (``NASDAQ'') each
offer a 10GB network connection option to their members, albeit at a
higher cost than that proposed by ISE.\5\
---------------------------------------------------------------------------

    \3\ 15 U.S.C. 78f .
    \4\ 15 U.S.C. 78f(b)(4).
    \5\ See Exchange Act Release Nos. 62639 (August 4, 2010), 75 FR
48391 (August 10, 2010) (SR-PHLX-2010-89); 62969 (September 22,
2010), 75 FR 59777 (September 28, 2010) (SR-BX-2010-064); and 62663
(August 9, 2010), 75 FR 49543 (August 13, 2010) (SR-NASDAQ-2010-
077). PHLX, BX and NASDAQ each charges $5,000 per month for a 10 GB
connection.
---------------------------------------------------------------------------

B. Self-Regulatory Organization's Statement on Burden on Competition

    The proposed rule change does not impose any burden on competition
that is not necessary or appropriate in furtherance of the purposes of
the Act.

C. Self-Regulatory Organization's Statement on Comments on the Proposed
Rule Change Received From Members, Participants or Others

    The Exchange has not solicited, and does not intend to solicit,
comments on this proposed rule change. The Exchange has not received
any unsolicited written comments from members or other interested
parties.

III. Date of Effectiveness of the Proposed Rule Change and Timing for
Commission Action

    The foregoing rule change has become effective pursuant to Section
19(b)(3)(A)(ii) of the Act.\6\ At any time within 60 days of the filing
of such proposed rule change, the Commission summarily may temporarily
suspend such rule change if it appears to the Commission that such
action is necessary or appropriate in the public interest, for the
protection of investors, or otherwise in furtherance of the purposes of
the Act. If the Commission takes such action, the Commission shall
institute proceedings to determine whether the proposed rule should be
approved or disapproved.
---------------------------------------------------------------------------

    \6\ 15 U.S.C. 78s(b)(3)(A)(ii).
---------------------------------------------------------------------------

IV. Solicitation of Comments

    Interested persons are invited to submit written data, views, and
arguments concerning the foregoing, including whether the proposed rule
change is consistent with the Act. Comments may be submitted by any of
the following methods:

Electronic Comments

     Use the Commission's Internet comment form http://www.sec.gov/rules/sro.shtml); or
     Send an e-mail to<EMAIL_ADDRESS>Please include
File No. SR-ISE-2011-22 on the subject line.

Paper Comments

     Send paper comments in triplicate to Elizabeth Murphy,
Secretary, Securities and Exchange Commission, 100 F Street, NE.,
Washington, DC 20549-1090.

All submissions should refer to File Number SR-ISE-2011-22. This file
number should be included on the subject line if e-mail is used. To
help the Commission process and review your comments more efficiently,
please use only one method. The Commission will post all comments on
the Commission's Internet Web site (http://www.sec.gov/rules/sro.shtml
). Copies of the submission, all subsequent amendments, all written
statements with respect to the proposed rule change that are filed with
the Commission, and all written communications relating to the proposed
rule change between the Commission and any person, other than those
that may be withheld from the public in accordance with the provisions
of 5 U.S.C. 552, will be available for Web site viewing and printing in
the Commission's Public Reference Room. Copies of such filing also will
be available for inspection and copying at the principal office of the
ISE. All comments received will be posted without change; the
Commission does not edit personal identifying information from
submissions. You should submit only information that you wish to make
available publicly. All submissions should refer to File Number SR-ISE-
2011-22 and should be submitted by May 6, 2011.

    For the Commission, by the Division of Trading and Markets,
pursuant to delegated authority.\7\
---------------------------------------------------------------------------

    \7\ 17 CFR 200.30-3(a)(12).
---------------------------------------------------------------------------

Cathy Ahn,
Deputy Secretary.
[FR Doc. 2011-9121 Filed 4-14-11; 8:45 am]
BILLING CODE 8011-01-P


92188065	Leslie, W. (1990) Mobay Corporation Phase 3 Summary of MRID 00128337. Triadimefon (BAYLETON 50WP Formulation) - Magnitude of the Residue in Unprocessed Sugar Beets and Sugar Beet Processed Products: Project Report Nos. 84211, 84212 and 82811; Mobay Report No. 100116-1. Prepared by MOBAY CORPORATION. 12 p.

92188069	Leslie, W. (1990) Mobay Corporation Phase 3 Reformat of MRID 00128337. Triadimefon (BAYLETON 50WP Formulation) - Magnitude of the residues in Unprocessed Sugar Beets and Sugar Beet processed Products: Project Nos. (82811, 84211, 84212); Mobay Report No. 100116. Prepared by MOBAY CORPORATION. 56 p.

92188070	Leslie, W. (1990) Mobay Corporation Phase 3 Reformat of MRID 00067381 and Related MRIDs 00109463. Triadimefon (BAYLETON 25WP Formulation) - Magnitude of the Residues on Chick Peas (Project Nos. 68905, 68906, 68907, 68908, 68909, 80723, 80930, 80931); Mobay Report No. 100117. Prepared by MOBAY CORPORATION. 55 p.

92188073	Leslie, W. (1990) Mobay Corporation Phase 3 Reformat of MRID 00128337. Triadimefon (BALETON 50WP) - Magnitude of the Residues on Sugar Beets: (Project Nos. 81198, 81199, 82205, 82206, 82207, 82800, 82801, 82802, 82812, 82813, 82814, 82815, 82816, 82817, 82818); Mobay Report No. 10115. Prepared by MOBAY CORPORATION. 204 p.

92188074	Leslie, W. (1990) Mobay Corporation Phase 3 Reformat of MRID 00098114 and Related MRIDs 00149329, 00061736. Triadimefon (BAYLETON 50WP Formulation) - Magnitude of the Residues on Wheat: (Report Nos. 80494, 80495, 80530, 80542, 80545, 80546, 80547, 80550, 80551, 80552, 80553, 82821, 82874, 84208, 82822, 82824); Mobay Report No. 100111. Prepared by MOBAY CORPORATION. 219 p.

92188075	Leslie, W. (1990) Mobay Corporation Phase 3 Reformat of MRID 00072532 and Related MRIDs 00149342. Triadimefon (BAYLETON 50WP Formulation) - Magnitude of the Residues on Seed Grass: Project Report Nos. (80670, 80673, 80674, 80675, 80676, 82848, 82854, 82855, 82856, 82857, 82858); Mobay Report 100114. Prepared by MOBAY CORPORATION. 121 p.

92188320	Bayer Ag Institute of Toxicology; Two Generation Study with Rats; Report No.: 12712, Report Author: Dr. R. Eiben (Also under MRIDs 00155075, 92188019 and TRID Number 470102-011).

None

None

None

None

None

None

None

None

None

None

None

None

None

None	  SEQ CHAPTER \h \r 1 Allen, J., Wolf, D., George, M. Hester, S., Sun G., Thai, S-F., Delker, D., Nelson, G., Winkfield, E. Roop, B., Leavitt, S., Ward, W., and Nesnow, S. (2005) Comparable Liver P450 Enzyme Activity and Histopathology in Mice Treated With the Conazole Fungicides: Myclobutanil, Propiconazole and Triadimefon. The Toxicologist. Abstract. No, 2146.

	Crofton, KM. 1996. A structure- activity relationship for the neurotoxicity of triazole fungicites.  Toxicol. Lett 84 (3): 155-159.

	Crofton, KM., Boneck, VM., and Reiter, LW. 1988.  Hyperactivity induced by triaedimefon, a triazole fungicide.  Fundam. Appl. Toxicol.  10, 459-465.

	Crofton, KM., Boneck, VM., and MacPhail, RC. 1989.  Evidence for monoaminergic involvement in triadimefon- induced hyperactivity, Psychopharmacology 97, 326-330.

	Crofton, KM., Howard, JL., Moser, VC., Gill, MW., et al. 1991.  Interlaboratory comparison of motor activity experiments: implications for neurotoxicological assessments.  Neurotoxicol. Teratol. 13 (6): 599- 609.

	Crofton, KM., Makris, SL., Sette, WF., Mendez, E., and Raffaele, KC. 2004.  A qualitative retrospective analysis of positive control data in developmental neurotoxicity studies.  Neurotoxicology and Teratology 26; 345-352.352.

	Goetz, A.K., Blystone, C., Ren, H., Schmid, J.E., Nichols, H.P., Bao, W., Best, D.S., Narotsky, M.G., Wolf, D.C., Rockett, J.C., and Dix, D.J. (2005) Reproductive Effects of Exposure to Conazole Fungicides in the Male Rat. The Toxicologist. Abstract No 2148.

	Golub, M., Costa, L., Crofton, K., Frank, D., Fried, P., Gladen, B., Henderson, R., Liebelt, E., Lusskin, S., Marty, S., Rowland, A., Scialli, J., and Vore, M. 2005.  NTP-CERHR expert panel report on the reproductive and developmental toxicity of methylphenidate.  Birth Defects Research (part B) 74:300-381.

	Hester, S., Thai, S.-F., Wolf, D., Ward, W., and Nesnow, S. (2005) Comparison of Gene Expression Profiles from Rats Fed Acute Levels of Three Toxicologically Different Conazoles. The Toxicologist. Abstract No. 2149.

	Ikaiddi, MU., Akunne, HC., and Soliman, KE. 1997. Behavioral and neurochemical effects of acute and repeated administration of triadimefon in the male rat.  Neurotoxicology 18(3): 771-80.

	Moser, VC and MacPhail, RC. 1989.  Neurobehavioral effects of triadimefon, a triazole fungicide, in male and female rats. Neurotoxicol. Teratol. 11, 285-293.

	Moser, VC and MacPhail, RC. 1992. International validation of the neurobehavioral screening battery: The IPCS/WHO collaborative study. Toxicol. Lett. 64-65 Spec. No., 217-223.

	Moser, VC., Cheek, BM., and MacPhail, RC.  1995. A multidisciplinary approach to toxicological screenings: III. Neurobehavioral toxicity.  Journal Toxicol Environ Health Jun 45(2): 173-210.

	Ren, H., Schmid, J.E., Retief, J., Turpaz, Y., Zhang, X., Jones, P.D., Newsted, J.L., Giesy, J.P., Wolf, D.C., Wood, C.R., Bao, W., and Dix, D.J. (2005) Profiling Gene Expression in Human H295R Adrenocortical Carcinoma Cells and Rat Testes to Identify Pathways of Toxicity for Conazole Fungicides. The Toxicologist. Abstract No. 2150.

None

None

None

None	Sun G, Thai SF, Tully DB, Lambert GR, Goetz AK, Wolf DC, Dix DJ, Nesnow S:  Propiconazole-induced cytochrome P450 gene expression and enzymatic activities in rat and mouse liver. Tox Lett 155: 277-287, 2004; and abstracts from the 2005 SOT meeting,

	Walker, QD and Mailman, RB. 1996.  Triadimefon and triadimenol: effects on monoamine uptake and release.  Toxicol. Appl. Pharmacol. 139 (2): 227- 233.

	Ward, W., Delker, D., Hester, S., Thai, S-F., Allen, J., Jones, C., Wolf, D., and Nesnow, S. (2005) Comparison of Hepatic Gene Expression Profiles from Mice Exposed to Three Toxicologically Different Conazoles. The Toxicologist. Abstract No. 2147.

	Wolf, D.C., Allen, J., Sun, G., Thibodeaux, J., George, M., Hester, S.D., Thai, S.-F., Delker, D., Nelson, G., Winkfield, E., Roop, B., Leavitt, S., Ward, W., and Nesnow, S. (2005) Triadimefon Induces Rat Thyroid Tumors Through a Non-TSH Mediated Mode of Action. The Toxicologist. Abstract No. 2144.

Appendix E.  Generic Data Call-In

Appendix E.

The generic data call-in will be posted at a later date.

Appendix F.  Product Specific Data Call-In

Appendix F.

The product specific data call-in will be posted at a later date.  SEQ CHAPTER \h \r 1 Appendix G: Batching of Triadimenol/Triadimefon Products

EPA'S BATCHING OF TRIADIMENOL/TRIADIMEFON PRODUCTS FOR MEETING ACUTE TOXICITY DATA REQUIREMENTS FOR REREGISTRATION

In an effort to reduce the time, resources and number of animals needed to fulfill the acute toxicity data requirements for reregistration of products containing TRIADIMENOL or TRIADIMEFON as the active ingredient, the Agency has batched products which can be considered similar for purposes of acute toxicity. Factors considered in the sorting process include each product's active and inert ingredients (identity, percent composition and biological activity), type of formulation (e.g., emulsifiable concentrate, aerosol, wettable powder, granular, etc.), and labeling (e.g., signal word, use classification, precautionary labeling, etc.).  Note that the Agency is not describing batched products as "substantially similar" since some products within a batch may not be considered chemically similar or have identical use patterns.

Using available information, batching has been accomplished by the process described in the preceding paragraph. Notwithstanding the batching process, the Agency reserves the right to require, at any time, acute toxicity data for an individual product should the need arise.

Registrants of products within a batch may choose to cooperatively generate, submit or cite a single battery of six acute toxicological studies to represent all the products within that batch. It is the registrants' option to participate in the process with all other registrants, only some of the other registrants, or only their own products within a batch, or to generate all the required acute toxicological studies for each of their own products.  If a registrant chooses to generate the data for a batch, he/she must use one of the products within the batch as the test material.  If a registrant chooses to rely upon previously submitted acute toxicity data, he/she may do so provided that the data base is complete and valid by today's standards (see acceptance criteria attached), the formulation tested is considered by EPA to be similar for acute toxicity, and the formulation has not been significantly altered since submission and acceptance of the acute toxicity data. Regardless of whether new data is generated or existing data is referenced, registrants must clearly identify the test material by EPA Registration Number. If more than one confidential statement of formula (CSF) exists for a product, the registrant must indicate the formulation actually tested by identifying the corresponding CSF.

In deciding how to meet the product specific data requirements, registrants must follow the directions given in the Data Call-In Notice and its attachments appended to the RED. The DCI Notice contains two response forms which are to be completed and submitted to the Agency within 90 days of receipt.  The first form, "Data Call-In Response," asks whether the registrant will meet the data requirements for each product.  The second form, "Requirements Status and Registrant's Response," lists the product specific data required for each product, including the standard six acute toxicity tests.  A registrant who wishes to participate in a batch must decide whether he/she will provide the data or depend on someone else to do so.  If a registrant supplies the data to support a batch of products, he/she must select one of the following options: Developing Data (Option 1), Submitting an Existing Study (Option 4), Upgrading an Existing Study (Option 5) or Citing an Existing Study (Option 6). If a registrant depends on another's data, he/she must choose among: Cost Sharing (Option 2), Offers to Cost Share (Option 3) or Citing an Existing Study (Option 6). If a registrant does not want to participate in a batch, the choices are Options 1,  4, 5 or 6. However, a registrant should know that choosing not to participate in a batch does not preclude other registrants in the batch from citing his/her studies and offering to cost share (Option 3) those studies.

Seven products were found which contain Triadimenol as the active ingredient.  These products have been placed in a no batch group in accordance with the active and inert ingredients and type of formulation

Batching Instructions for Triadimenol:

No Batch:  Each product in this Batch should generate their own data.

NOTE: The technical acute toxicity values included in this document are for informational purposes only.  The data supporting these values may or may not meet the current acceptance criteria.

No Batch	EPA Reg. No.	Percent Active Ingredient

	264-742	25.00

	264-743	98.30

	264-760	28.30

	264-939	Triademinol:  5.00

Tetramethylthiuram disulfide:  15.30

	264-941	30.00

	264-980	Triademinol:  13.33

Azoxystrobin:  8.00

Metalaxyl:  40.00

	2935-459	30.00

Fifty one products were found which contain Triadimefon as the active ingredient.  These products have been placed in seven batches and a no batch group in accordance with the active and inert ingredients and type of formulation.

Batching Instructions for Triadimefon:

Batch 3A:  Products in this Batch may cite studies conducted on products in Batch 3.

Batch 6:  Each product in this Batch must conduct a primary eye irritation study using the fertilizer with the highest percentage of nitrogen.

No Batch:  Each product in this Batch should generate their own data.

NOTE: The technical acute toxicity values included in this document are for informational purposes only.  The data supporting these values may or may not meet the current acceptance criteria.

Batch 1	EPA Reg. No.	Percent Active Ingredient

	264-737	50.0

	264-740	50.0

	432-1294	50.0

	432-1360	50.0

	432-1367	50.0

Batch 2	EPA Reg. No.	Percent Active Ingredient

	432-1293	25.0

	432-1309	25.0

	432-1316	25.0

	432-1317	25.0

Batch 3	EPA Reg. No.	Percent Active Ingredient

	4-342	1.0

	432-1295	1.0

	432-1336	1.0

	961-354	1.0

	8378-55	1.0

	9198-111	1.0

	10404-58	1.0

	28293-278	1.0

	32802-41	1.0

	34704-802	1.0

Batch 3A	EPA Reg. No.	Percent Active Ingredient

	4-362	0.50

	432-1296	0.50

	869-224	0.50

	829-288	0.50

	961-353	0.50

	7401-432	0.50

	8378-54	0.50

	8660-199	0.78

	9198-112	0.50

	9198-187	0.59

	28293-280	0.50

	32802-42	0.50

	72155-47	0.50

Batch 4	EPA Reg. No.	Percent Active Ingredient

	432-1297	0.88

	829-289	0.88

	72155-48	0.88

Batch 5	EPA Reg. No.	Percent Active Ingredient

	869-222	0.88

	2724-691	0.88

Batch 6	EPA Reg. No.	Percent Active Ingredient

	961-388	0.10

	961-389	0.05

	9198-190	0.62

	10404-65	0.50

No Batch 	EPA Reg. No.	Percent Active Ingredient

	264-736	97.70

	264-757	Triadimefon:  2.10

Sulfur:  53.70

	432-1300	22.00

	432-1412	Triadimefon:  8.33

Trifloxystrobin:  41.67

	432-1445	43.00

	432-1446	Triadimefon:  20.86

Trifloxystrobin:  4.17

	9198-169	Triadimefon:  16.00

Metalaxyl:  16.00

	9198-197	Triadimefon:  1.59

Thiram:  40.76

	64014-3	0.88

	72155-46	1.00

H.	List of Registrants Sent this Data Call-In

United States Environmental Protection Agency

Washington, D.C.  20460

LIST OF ALL REGISTRANTS SENT THIS DATA CALL-IN NOTICE

Case # and Name:	2700, Triadimefon

Co. Number	Company Name	Agent for	Address	City and State	Zip

264

BAYER CROPSCIECNCE

2 T.W. Alexander Drive

Research Triangle Park

NC 27709

Appendix I.  List of Available Related Documents and Electronically Available Forms

		  SEQ CHAPTER \h \r 1 Pesticide Registration Forms are available at the following EPA internet site:

		http://www.epa.gov/opprd001/forms/.

Pesticide Registration Forms (These forms are in PDF format and require the Acrobat reader)

Instructions

	1.	Print out and complete the forms. (Note: Form numbers that are bolded can be filled out on your computer then printed.)

	2.	The completed form(s) should be submitted in hardcopy in accord with the existing policy.

      	3.	Mail the forms, along with any additional documents necessary to comply with EPA regulations covering your request, to the address below for the Document Processing Desk.

DO NOT fax or e-mail any form containing 'Confidential Business Information' or 'Sensitive Information.'

If you have any problems accessing these forms, please contact Nicole Williams at<PHONE_NUMBER> or by e-mail at <EMAIL_ADDRESS> The following Agency Pesticide Registration Forms are currently available via the internet:

at the following locations:

8570-1	Application for Pesticide Registration/Amendment http://www.epa.gov/opprd001/forms/8570-1.pdf.

8570-4	Confidential Statement of Formula http://www.epa.gov/opprd001/forms/8570-4.pdf.

8570-5	Notice of Supplemental Registration of Distribution of a Registered Pesticide Product  http://www.epa.gov/opprd001/forms/8570-5.pdf.

8570-17	Application for an Experimental Use Permit http://www.epa.gov/opprd001/forms/8570-17.pdf.

8570-25	Application for/Notification of State Registration of a Pesticide To Meet a Special Local Need  http://www.epa.gov/opprd001/forms/8570-25.pdf.

8570-27	Formulator's Exemption Statement http://www.epa.gov/opprd001/forms/8570-27.pdf.

8570-28	Certification of Compliance with Data Gap Procedures  http://www.epa.gov/opprd001/forms/8570-28.pdf.

8570-30	Pesticide Registration Maintenance Fee Filing  http://www.epa.gov/opprd001/forms/8570-30.pdf.

8570-32	Certification of Attempt to Enter into an Agreement with other Registrants for Development of Data  http://www.epa.gov/opprd001/forms/8570-32.pdf.

8570-34	Certification with Respect to Citations of Data  (in PR Notice 98-5)	http://www.epa.gov/opppmsd1/PR_Notices/pr98-5.pdf.

8570-35	Data Matrix  (in PR Notice 98-5) http://www.epa.gov/opppmsd1/PR_Notices/pr98-5.pdf.

8570-36	Summary of the Physical/Chemical Properties  (in PR Notice 98-1) http://www.epa.gov/opppmsd1/PR_Notices/pr98-1.pdf.

8570-37	Self-Certification Statement for the Physical/Chemical Properties  (in PR Notice 98-1) http://www.epa.gov/opppmsd1/PR_Notices/pr98-1.pdf.

Pesticide Registration Kit		www.epa.gov/pesticides/registrationkit/.

Dear Registrant:

	For your convenience, we have assembled an online registration kit which contains the following pertinent forms and information needed to register a pesticide product with the U.S. Environmental Protection Agency's Office of Pesticide Programs (OPP):

	1.	The Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) and the Federal Food, Drug and Cosmetic Act (FFDCA) as Amended by the Food Quality Protection Act (FQPA) of 1996.

	2.	Pesticide Registration (PR) Notices

		a.	83-3 Label Improvement Program--Storage and Disposal Statements

		b.	84-1 Clarification of Label Improvement Program

		c.	86-5 Standard Format for Data Submitted under FIFRA

		d.	87-1 Label Improvement Program for Pesticides Applied through Irrigation Systems (Chemigation)

		e.	87-6 Inert Ingredients in Pesticide Products Policy Statement

		f.	90-1 Inert Ingredients in Pesticide Products; Revised Policy Statement

		g.	95-2 Notifications, Non-notifications, and Minor Formulation Amendments

		h.	98-1 Self Certification of Product Chemistry Data with Attachments  (This document is in PDF format and requires the Acrobat reader.)

	Other PR Notices can be found at http://www.epa.gov/opppmsd1/PR_Notices.

	3.	Pesticide Product Registration Application Forms (These forms are in PDF format and will require the Acrobat reader.)

		a.	EPA Form No. 8570-1, Application for Pesticide Registration/Amendment

		b.	EPA Form No. 8570-4, Confidential Statement of Formula

		c.	EPA Form No. 8570-27, Formulator's Exemption Statement

		d.	EPA Form No. 8570-34, Certification with Respect to Citations of Data

		e.	EPA Form No. 8570-35, Data Matrix

	4.	General Pesticide Information (Some of these forms are in PDF format and will require the Acrobat reader.)

		a.	Registration Division Personnel Contact List

	b.	Biopesticides and Pollution Prevention Division (BPPD) Contacts

		c.	Antimicrobials Division Organizational Structure/Contact List

		d.	53 F.R. 15952, Pesticide Registration Procedures; Pesticide Data Requirements (PDF format)

		e. 	40 CFR Part 156, Labeling Requirements for Pesticides and Devices (PDF format)

		f.. 	40 CFR Part 158, Data Requirements for Registration (PDF format)

		g.. 	50 F.R. 48833, Disclosure of Reviews of Pesticide Data (November 27, 1985)

Before submitting your application for registration, you may wish to consult some additional sources of information.   These include:

	1.	The Office of Pesticide Programs' Web Site

	2.	The booklet "General Information on Applying for Registration of Pesticides in the United States", PB92-221811, available through the National Technical Information Service (NTIS) at the following address:

			National Technical Information Service (NTIS)

			5285 Port Royal Road

			Springfield, VA 22161

The telephone number for NTIS is<PHONE_NUMBER>.

	3.	The National Pesticide Information Retrieval System (NPIRS) of Purdue University's Center for Environmental and Regulatory Information Systems. This service does charge a fee for subscriptions and custom searches. You can contact NPIRS by telephone at<PHONE_NUMBER> or through their Web site.

4.	The National Pesticide Telecommunications Network (NPTN) can provide information on active ingredients, uses, toxicology, and chemistry of pesticides. You can contact NPTN by telephone at<PHONE_NUMBER> or through their Web site: ace.orst.edu/info/nptn.

The Agency will return a notice of receipt of an application for registration or amended registration, experimental use permit, or amendment to a petition if the applicant or petitioner encloses with his submission a stamped, self-addressed postcard. The postcard must contain the following entries to be completed by OPP:

Date of receipt;

EPA identifying number; and

Product Manager assignment.

		Other identifying information may be included by the applicant to link the acknowledgment of receipt to the specific application submitted. EPA will stamp the date of receipt and provide the EPA identifying File Symbol or petition number for the new submission. The identifying number should be used whenever you contact the Agency concerning an application for registration, experimental use permit, or tolerance petition.

-

)

옍

-

&

(

)

9

;

<

@

A

R

U

W

Y

k

)

<

U

n

Œ

¬

Á

à

ù

D

e

™

½

×

摧崛!ᜀk

n

p

r

‰

‹

Ž

’

”

©

ª

«

¬

¾

À

Æ

Ç

Ý

ß

à

ä

è

ö

ø

ù

û

0

@

C

G

a

d

h

•

˜

™

ž

¹

¼

½

À

Ã

Ò

Õ

×

Û

Ý

î

ï

(ï

ñ

ò

ó

ö

ø

×

ò

摧崛!

&

 h4T

萑ː葠ː摧崛!

'

 hé

摧崛!

摧崛!

摧崛!

摧崛!

摧崛!

摧崛!

摧崛!

摧崛!

摧崛!

摧崛!

摧崛!

摧崛!

摧崛!

摧崛!

摧崛!

  h

愀Ĥ摧崛!

&

 h({

옍)

옍)

옍)

옍)

"̀Ĥ옍)

摧崛!$̀Ĥ옍)

$̀Ĥ옍)

$̀Ĥ옍)

$̀Ĥ옍)

$̀Ĥ옍)

옍)

옍)

a

b

j

l

–

—

º

Ò

Ó

萑ː葠ː摧崛!଀÷

옍)

瑹崛!Ā

萎萑ː葝葠ː摧㴎଀

摧崛!ऀ

 h¶

耀☆

摧崛!

摧崛!

摧崛!

摧崛!

옍)

옍)

옍)

옍)

옍)

 hþ^

愀Ĥ摧崛!

愀Ĥ摧崛!

愀Ĥ摧崛!

-਀&䘋	옍)

摧崛!

摧崛!

摧崛!

摧崛!

摧崛!

ਁ氃愀϶l瑹崛!

摧崛!

摧崛!

摧崛!

愀Ĥ摧崛!

愀Ĥ摧崛!

愀Ĥ摧崛!

愀Ĥ摧崛!

…

愀Ĥ摧崛!

h#

h#

h#

 hN

F

G

H

K

M

N

i

j

G

H

j

k

摧䄱{ጀj

k

l

€

h

h

h

k

愀Ĥ摧笅ã

愀Ĥ摧笅ã

愀Ĥ摧笅ã

愀Ĥ摧笅ã

愀Ĥ摧笅ã

愀Ĥ摧笅ã

愀Ĥ摧笅ã

愀Ĥ摧笅ã

愀Ĥ摧笅ã

愀Ĥ摧笅ã

愀Ĥ摧笅ã

愀Ĥ摧笅ã

愀Ĥ摧笅ã

愀Ĥ摧笅ã

愀Ĥ摧笅ã

愀Ĥ摧笅ã

愀Ĥ摧笅ã

k

愀Ĥ摧笅ã

k

愀Ĥ摧笅ã

愀Ĥ摧笅ã

愀Ĥ摧笅ã

愀Ĥ摧笅ã

愀Ĥ摧笅ã

愀Ĥ摧笅ã

愀Ĥ摧笅ã

愀Ĥ摧笅ã

愀Ĥ摧笅ã

愀Ĥ摧笅ã

愀Ĥ摧笅ã

愀Ĥ摧笅ã

愀Ĥ摧笅ã

愀Ĥ摧笅ã

愀Ĥ摧笅ã

愀Ĥ摧笅ã

愀Ĥ摧笅ã

愀Ĥ摧笅ã

愀Ĥ摧笅ã

愀Ĥ摧笅ã

愀Ĥ摧笅ã

愀Ĥ摧笅ã

愀Ĥ摧笅ã

愀Ĥ摧笅ã

愀Ĥ摧笅ã

摧笅ã

摧笅ã

愀Ĥ摧笅ã

愀Ĥ摧笅ã

愀Ĥ摧笅ã

愀Ĥ摧笅ã

愀Ĥ摧笅ã

愀Ĥ摧笅ã

愀Ĥ摧笅ã

愀Ĥ摧笅ã

愀Ĥ摧笅ã

愀Ĥ摧笅ã

愀Ĥ摧笅ã

愀Ĥ摧笅ã

愀Ĥ摧笅ã

愀Ĥ摧笅ã

愀Ĥ摧笅ã

愀Ĥ摧笅ã

愀Ĥ摧笅ã

愀Ĥ摧笅ã

愀Ĥ摧笅ã

愀Ĥ摧笅ã

愀Ĥ摧笅ã

愀Ĥ摧笅ã

愀Ĥ摧笅ã

愀Ĥ摧笅ã

愀Ĥ摧笅ã

愀Ĥ摧笅ã

愀Ĥ摧笅ã

愀Ĥ摧笅ã

愀Ĥ摧笅ã

愀Ĥ摧笅ã

愀Ĥ摧笅ã

愀Ĥ摧笅ã

愀Ĥ摧笅ã

愀Ĥ摧笅ã

愀Ĥ摧笅ã

愀Ĥ摧笅ã

਀&䘋

h<

਀&䘋

਀&䘋

਀&䘋

摧㣅Û

 h8r

  h8r

 h8r

  h8r

摧㴷a

摧㴷a

摧㴷a

摧㴷a

	”

h`



Á

Á

ā⬃㐀ۖĀ̊H䠃昀Ĵ瑹瀭%

h

ā⬃㐀ۖĀ̊H䠃昀Ĵ瑹瀭%

Á

Á

ā⬃㐀ۖĀ̊H䠃昀Ĵ瑹瀭%

ā⬃㐀ۖĀ̊H䠃昀Ĵ瑹瀭%

Á

Á

ā⬃㐀ۖĀ̊H䠃昀Ĵ瑹瀭%

摧ᤛì

摧⡱=

Á

Á

ā⬃㐀ۖĀ̊H䠃昀Ĵ瑹瀭%

摧⡱=

h

 h

h

摧⡱=

h

h

h

摧ᤛì

摧ᤛì

h

h

摧⡱=

@

„@

„Àô^„@

`„Àôgd

`„`úgd

gd

$a$gd

`„`úgd

愀Ĥ摧㼲Ù

h

h

h

h

h

h

h

h

h

h

h

h

h

h

h

h

h

h

+

/

0

8

9

>

?

X

Y

\

]

`

a

b

j

k

p

q

s

t

w

x

€

‚

Š

‹

¥

¦

©

ª

®

¯

·

¸

½

¾

Ç

È

Õ

Ö

Þ

ß

ã

ä

ñ

ò

õ

ö

þ

h

h

h

h

h

h

h

'

+

/

Y

]

a

t

x

¦

ª

®

È

Ì

Õ

ò

ö

ÿ

愀Ĥ摧㼲ÙȀþ

ÿ

h

h

h

h

h

h

h

h

h

愀Ĥ摧㼲Ù

N

Q

R

[

\

]

e

f

j

k

y

z

}

~

†

‡

ˆ

š

›

œ

¤

¥

©

ª

Ã

Å

×

Ø

Ù

á

â

ç

è

h

h

h

h

h

h

h

h

h

h

N

R

S

\

愀Ĥ摧㼲Ù

z

~

‡

愀Ĥ摧㼲ÙȀ‡

ˆ

›

\

愀Ĥ摧㼲Ù

kdä

Ø

Ù

\

Ù

â

è

愀Ĥ摧㼲Ù

kdò

\

愀Ĥ摧㼲Ù

\

愀Ĥ摧㼲Ù

h

h

  hU#

h

h

h

h

h

h

h

\

愀Ĥ摧㼲Ù

\

愀Ĥ摧㼲Ù

\

愀Ĥ摧㼲Ù

\

愀Ĥ摧㼲Ù

\

愀Ĥ摧㼲Ù

\

h

h

h

h

h

h

h

h

h

h

h

h

愀Ĥ摧㼲Ù

\

愀Ĥ摧㼲Ù

\

愀Ĥ摧㼲Ù

\

愀Ĥ摧㼲Ù

\

愀Ĥ摧㼲Ù

h

h

h

h

h

h

h

h

\

愀Ĥ摧㼲Ù

\

愀Ĥ摧㼲Ù

\

愀Ĥ摧㼲Ù

\

愀Ĥ摧㼲Ù

\

愀Ĥ摧㼲Ù

\

愀Ĥ摧㼲Ù

\

愀Ĥ摧㼲Ù

\

h

h

h

h

h

h

h

愀Ĥ摧㼲Ù

\

\

愀Ĥ摧㼲Ù

\

愀Ĥ摧㼲Ù

\

愀Ĥ摧㼲Ù

\

愀Ĥ摧㼲Ù

\

愀Ĥ摧㼲Ù

\

愀Ĥ摧㼲Ù

h

h

h

h

h

h

h

\

愀Ĥ摧㼲Ù

\

愀Ĥ摧㼲Ù

\

愀Ĥ摧㼲Ù

\

愀Ĥ摧㼲Ù

\

愀Ĥ摧㼲Ù

\

愀Ĥ摧㼲Ù

\

愀Ĥ摧㼲Ù

\

愀Ĥ摧㼲Ù

\

愀Ĥ摧㼲Ù

h

h

h

h

h

\

愀Ĥ摧㼲Ù

\

愀Ĥ摧㼲Ù

\

愀Ĥ摧㼲Ù

\

愀Ĥ摧㼲Ù

\

愀Ĥ摧㼲Ù

\

愀Ĥ摧㼲Ù

\

愀Ĥ摧㼲Ù

\

愀Ĥ摧㼲Ù

\

愀Ĥ摧㼲Ù

\

愀Ĥ摧㼲Ù

\

愀Ĥ摧㼲Ù

h

h

h

h

h

h

h

h

\

愀Ĥ摧㼲Ù

\

愀Ĥ摧㼲Ù

\

愀Ĥ摧㼲Ù

\

愀Ĥ摧㼲Ù

愀Ĥ摧㼲Ù

愀Ĥ摧㼲Ù

愀Ĥ摧㼲Ù

h

h

h

h

h

愀Ĥ摧㼲Ù

愀Ĥ摧㼲Ù

愀Ĥ摧㼲Ù

愀Ĥ摧㼲Ù

愀Ĥ摧㼲Ù

愀Ĥ摧㼲Ù

愀Ĥ摧㼲Ù

愀Ĥ摧㼲Ù

愀Ĥ摧㼲Ù

愀Ĥ摧㼲Ù

摧㼲ÙԀ

h

h

h

h

h

h

愀Ĥ摧㼲Ù

愀Ĥ摧㼲Ù

愀Ĥ摧㼲Ù

愀Ĥ摧㼲Ù

愀Ĥ摧㼲Ù

愀Ĥ摧㼲Ù

愀Ĥ摧㼲Ù

愀Ĥ摧㼲Ù

愀Ĥ摧㼲Ù

h

h

h

h

h

h

h

h

摧㼲Ù

愀Ĥ摧㼲Ù

愀Ĥ摧㼲Ù

愀Ĥ摧㼲Ù

愀Ĥ摧㼲Ù

愀Ĥ摧㼲Ù

愀Ĥ摧㼲Ù

h

愀Ĥ摧㼲Ù

愀Ĥ摧㼲Ù

愀Ĥ摧㼲Ù

gd

$a$gd

h

h

h

h

h

h

h

h

h

h

愀Ĥ摧㼲Ù

\

愀Ĥ摧㼲Ù

h

h

h

h

h

h

h

\

愀Ĥ摧㼲Ù

\

愀Ĥ摧㼲Ù

\

愀Ĥ摧㼲Ù

h

h

h

h

h

h

h

h

h

h

h

h

h

h

h

h

h

h

h

h

愀Ĥ摧㼲Ù

h

h

h

h

h

h

h

h

h

h

h

h

h

h

h

愀Ĥ摧㼲Ù

\

h

h

h

h

h

h

h

愀Ĥ摧㼲Ù

\

愀Ĥ摧㼲Ù

\

愀Ĥ摧㼲Ù

\

愀Ĥ摧㼲Ù

\

愀Ĥ摧㼲Ù

\

愀Ĥ摧㼲Ù

\

愀Ĥ摧㼲Ù

\

h

h

h

h

愀Ĥ摧㼲Ù

\

愀Ĥ摧㼲Ù

\

愀Ĥ摧㼲Ù

\

愀Ĥ摧㼲Ù

\

愀Ĥ摧㼲Ù

\

愀Ĥ摧㼲Ù

\

愀Ĥ摧㼲Ù

\

愀Ĥ摧㼲Ù

\

愀Ĥ摧㼲Ù

\

愀Ĥ摧㼲Ù

\

h

h

h

h

h

h

h

h

h

愀Ĥ摧㼲Ù

\

愀Ĥ摧㼲Ù

\

愀Ĥ摧㼲Ù

\

愀Ĥ摧㼲Ù

\

愀Ĥ摧㼲Ù

\

愀Ĥ摧㼲Ù

\

愀Ĥ摧㼲Ù

\

愀Ĥ摧㼲Ù

\

愀Ĥ摧㼲Ù

\

愀Ĥ摧㼲Ù

h

h

h

h

h

h

h

h

愀Ĥ摧㼲Ù

摧㼲Ù

愀Ĥ摧㼲Ù

愀Ĥ摧㼲Ù

愀Ĥ摧㼲Ù

愀Ĥ摧㼲Ù

愀Ĥ摧㼲Ù

h

h

h

h

  hU#

h

 hU#

h

h

h

h

h

h

h

h

愀Ĥ摧㼲Ù

愀Ĥ摧㼲Ù

愀Ĥ摧㼲Ù

愀Ĥ摧㼲Ù

gd

h

h

h

h

h

h

h

h

h

h

h

h

„Ð^„Ðgd

`„0ýgd

„Ð`„Ðgd

€gd

`„²gd

h

gd

h

h

h

h

h

h

h

h

h

h

h

h

h

h

h

h

h

h

h

h

h

h

h

h

h

h

kdŠ

kdb

h

h

h

h

h

瑹㼲Ù̀

h

h

h

h

h

h

h

h

h

h

h

h

h

h

h

h

h

h

h

h

h

h

h

h

h

h

h

h

h

h

h

h

h

h

h

h

h

h

h

h

h

h

h

h

h

h

h

h

h

h

h

h

h

h

€gd

gd

h

h

h

h

h

h

h

h

h

h

h

h

h

h

h

h

h

gd

gd

„Ð`„Ðgd

gd

gd

gd

gd

gd

gd

gd

gd

gd

`„`úgd

gd

gd

&

ÿgd

摧㠍Ù

h

h

h

h

h

`„`úgd

gd

@

`„ðñgd

gd

`„`úgd

Æ

÷gd

gd

؀Ĥ옍

옍

&

ÿ^„Ðgd

&

Æ

÷gd

&

`„`úgd

&

ÿgd

`„`úgd

&

ÿgd

&

gd

gd

&

`„0ýgd

搒Ý␱㜀$␸䠀$摧㠍ÙԀassist us in ensuring that all data you have submitted for the chemical are properly coded and assigned to your company, please include a list of all synonyms, common and trade names, company experimental codes, and other names which identify the chemical (including "blind" codes used when a sample was submitted for testing by commercial or academic facilities). Please provide a chemical abstract system (CAS) number if one has been assigned.

Documents Associated with this RED

	The following documents are part of the Administrative Record for this RED document and may be included in the EPA's Office of Pesticide Programs Public Docket.  Copies of these documents are not available electronically, but may be obtained by contacting the person listed on the respective Chemical Status Sheet.

	1. 	Health Effects Division and Environmental Fate and Effects Division Science Chapters, which include the complete risk assessments and supporting documents.

	  2. 	Detailed Label Usage Information System (LUIS) Report.

 Bayer no longer wishes to support these uses.  The Agency will take regulatory action under FFDCA to revoke the associated tolerances.

 PAGE

 PAGE   20

 PAGE  126


[Federal Register Volume 84, Number 167 (Wednesday, August 28, 2019)]
[Notices]
[Pages 45145-45146]
[FR Doc No: 2019-18474]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Docket No. RM98-1-000]

Records Governing Off-the-Record Communication; Public Notice

    This constitutes notice, in accordance with 18 CFR 385.2201(b), of
the receipt of prohibited and exempt off-the-record communications.
    Order No. 607 (64 FR 51222, September 22, 1999) requires Commission
decisional employees, who make or receive a prohibited or exempt off-
the-record communication relevant to the merits of a contested
proceeding, to deliver to the Secretary of the Commission, a copy of
the communication, if written, or a summary of the substance of any
oral communication.
    Prohibited communications are included in a public, non-decisional
file associated with, but not a part of, the decisional record of the
proceeding. Unless the Commission determines that the prohibited
communication and any responses thereto should become a part of the
decisional record, the prohibited off-the-record communication will not
be considered by the Commission in reaching its decision. Parties to a
proceeding may seek the opportunity to respond to any facts or
contentions made in a prohibited off-the-record communication, and may
request that the Commission place the prohibited communication and
responses thereto in the decisional record. The Commission will grant
such a request only when it determines that fairness so requires. Any
person identified below as having made a prohibited off-the-record
communication shall serve the document on all parties listed on the
official service list for the applicable proceeding in accordance with
Rule 2010, 18 CFR 385.2010.
    Exempt off-the-record communications are included in the decisional
record of the proceeding, unless the communication was with a
cooperating agency as described by 40 CFR 1501.6, made under 18 CFR
385.2201(e) (1) (v).

    The following is a list of off-the-record communications recently
received by the Secretary of the Commission. The communications listed
are grouped by docket numbers in ascending order. These filings are
available for electronic review at the Commission in the Public
Reference Room or may be viewed on the Commission's website at http://www.ferc.gov using the eLibrary link. Enter the docket number,
excluding the last three digits, in the docket number field to access
the document. For assistance, please contact FERC Online Support at
<EMAIL_ADDRESS>or toll free at<PHONE_NUMBER>, or for TTY,
contact<PHONE_NUMBER>.

------------------------------------------------------------------------
                                                        Presenter or
            Docket No.                 File date          requester
------------------------------------------------------------------------
Prohibited:
None..............................
Exempt:
CP18-46-000.......................        8-6-2019  Pennsylvania
                                                     Department of
                                                     Community &
                                                     Economic
                                                     Development.
------------------------------------------------------------------------

    Dated: August 21, 2019.
Nathaniel J. Davis, Sr.,
Deputy Secretary.
[FR Doc. 2019-18474 Filed 8-27-19; 8:45 am]
BILLING CODE 6717-01-P


[Federal Register: March 13, 2007 (Volume 72, Number 48)]
[Notices]
[Page 11342-11343]
[DOCID:fr13mr07-30]

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Docket Nos. ER07-340-000; ER07-340-001]

Bell Independent Power Corporation; Notice of Issuance of Order

March 7, 2007.
    Bell Independent Power Corporation (Bell IPC) filed an application
for market-based rate authority, with an accompanying rate tariff. The
proposed market-based rate tariff provides for the sale of energy and
capacity at market-based rates. Bell IPC also requested waivers of
various Commission regulations. In particular, Bell IPC requested that
the Commission grant blanket approval under 18 CFR part 34 of all
future issuances of securities and assumptions of liability by Bell
IPC.

    On March 7, 2007, pursuant to delegated authority, the Director,
Division of Tariffs and Market Development--West, granted the requests
for blanket approval under part 34. The Director's order also stated
that the Commission would publish a separate notice in the Federal
Register establishing a period of time for the filing of protests.
Accordingly, any person desiring to be heard or to protest the blanket
approvals of issuances of securities or assumptions of liability by
Bell IPC should file a motion to intervene or protest with the Federal
Energy Regulatory Commission, 888 First Street, NE., Washington, DC
20426, in accordance with Rules 211 and 214 of the Commission's Rules
of Practice and Procedure. 18 CFR 385.211, 385.214 (2004).
    Notice is hereby given that the deadline for filing motions to
intervene or protest is April 4, 2007.
    Absent a request to be heard in opposition by the deadline above,
Bell IPC is authorized to issue securities and assume obligations or
liabilities as a guarantor, indorser, surety, or otherwise in respect
of any security of another person; provided that such issuance or
assumption is for some lawful object within the corporate purposes of
Bell IPC, compatible with the public interest, and is reasonably
necessary or appropriate for such purposes.
    The Commission reserves the right to require a further showing that
neither public nor private interests will be adversely affected by
continued approvals of Bell IPC's issuance of securities or assumptions
of liability.
    Copies of the full text of the Director's Order are available from
the Commission's Public Reference Room, 888 First Street, NE.,
Washington, DC 20426. The Order may also be viewed on the Commission's
Web site at  http://www.ferc.gov, using the eLibrary link. Enter the

docket number excluding the last three digits in the docket number
filed to access the document. Comments, protests, and interventions may
be filed electronically via the Internet in lieu of paper. See, 18 CFR
385.2001(a)(1)(iii) and the instructions on the Commission's Web site
under the ``e-Filing'' link. The Commission strongly encourages
electronic filings.

Philis J. Posey,
Acting Secretary.
[FR Doc. E7-4475 Filed 3-12-07; 8:45 am]

BILLING CODE 6717-01-P